已收盤 02-06 16:00:00 美东时间
+0.332
+0.37%
In the latest quarter, 6 analysts provided ratings for Ionis Pharmaceuticals (N...
02-07 05:00
UPDATE 2-Pandora to launch platinum-plated line to cut reliance on volatile silver market Adds share and Pandora prices in paragraphs 4-5, comments on U.S. and platinum price in paragraphs 6 and 8 By Helen Reid LONDON, Feb 5 (Reuters) - Jewellery brand Pandora is introducing platinum-plated products
02-05 15:44
BRIEF-JP Morgan Sees India Trimming Sanctioned Counterparties While Sustaining Russian Oil Flows Feb 4 (Reuters) - JP MORGAN: IN ITS BASE CASE SAYS INDIA WILL LARGELY EXIT SANCTIONED COUNTERPARTIES BUT CONTINUE IMPORTING RUSSIAN CRUDE AT AROUND 0.8–1.0 MBD, ACCOUNTING FOR 17–21% OF TOTAL CRUDE IMPO
02-04 20:19
BRIEF-MPLX LP Reports Q4 Results Feb 3 (Reuters) - MPLX LP MPLX.N : MPLX Q4 NET INCOME USD 1,193 MILLION MPLX Q4 PRETAX PROFIT USD 1,206 MILLION MPLX Q4 INCOME FROM OPERATIONS USD 1,483 MILLION MPLX Q4 OPERATING EXPENSES USD 419 MILLION MPLX Q4 ADJUSTED EBITDA USD 1,804 MILLION VERSUS. IBES ESTIMATE
02-03 21:19
FOCUS-Kuwait readies $7 billion pipeline deal as Gulf turns to foreign capital Kuwait planning $7 billion pipeline stake sale in Feb -sources KPC has added HSBC to list of advisers on deal -sources Saudi Aramco plans $4 bln power plant sale within weeks -sources Up to $15 bln in infrastructure deals
01-28 23:32
FACTBOX-Five takeaways from 'Big Short' investor Burry's GameStop bet Jan 27 (Reuters) - Michael Burry has disclosed a position in videogame retailer GameStop GME.N , playing down the odds of another major short squeeze and likening its CEO, Ryan Cohen, to legendary investor Warren Buffett. For Burr
01-27 22:09
UPDATE 1-Intellia gets FDA nod to resume gene therapy trial after safety pause Adds details and background throughout Jan 27 (Reuters) - Intellia Therapeutics NTLA.O said on Tuesday that the U.S. drug regulator has lifted a clinical hold on one of its late-stage gene therapy trials, allowing the com
01-27 21:29
BUZZ-Intellia jumps as FDA lifts hold on gene‑editing trial for rare nerve disease ** Shares of gene therapy developer Intellia Therapeutics NTLA.O rise 21% to $16.87 premarket ** Co says U.S. FDA has lifted clinical hold on its late‑stage trial testing nex‑z for hereditary ATTR amyloidosis with pol
01-27 21:20
BRIEF-Pursuit Announces Strategic Actions To Boost Shareholder Value, Refocus On Attractions And Hospitality Jan 21 (Reuters) - Pursuit Attractions and Hospitality Inc PRSU.N : PURSUIT ANNOUNCES STRATEGIC ACTIONS TO ENHANCE SHAREHOLDER VALUE AND ACCELERATES FOCUS ON ICONIC ATTRACTIONS AND HOSPITALIT
01-21 20:03
BRIEF-Brogent Technologies To Buy Pursuit's Flyover Attractions For $78.4 Mln Jan 21 (Reuters) - Brogent Technologies Inc 5263.TWO : SAYS TO BUY 100% STAKE IN PURSUIT'S FLYOVER ATTRACTIONS FOR $78.4 MILLION Source text: ID:nMOP1bjN2m Source text: ID:nMOP4tYB5r Further company coverage: 5263.TWO (Rep
01-21 17:41